# Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases

> **NCT02265549** · — · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 155 (actual)

## Conditions studied

- Metastases, Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02265549
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-09-04
- **Final completion:** 2014-09-04
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2018-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02265549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02265549, "Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02265549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*